EFFINGHAM CO., GA (WTOC) - The Effingham Health System has agreed to pay the nation's largest penalty settlement of its kind to resolve allegations the health system failed to provide effective controls and procedures to guard against theft and loss of controlled substances, leading to significant diversion of opioids and failing to timely report the suspected diversion to the Drug Enforcement Administration.
The health system has agreed to pay $4.1 million to resolve the allegations.
The DEA launched the investigation in 2017 after receiving reports of diversion at Effingham Health System.
The release from the United States Attorney's Office states, "DEA determined that tens of thousands of oxycodone 30mg tablets were unaccounted for, and were believed to have been diverted over more than a four-year period, in violation of the hospital's responsibilities under the Controlled Substances Act. DEA also determined that Effingham Health System failed to notify DEA of the suspected diversion within the time required by federal law."
The release also states, "Effingham Health System cooperated with the DEA's investigation and, prior to this investigation, overhauled its pharmacy operations to help ensure that it will avoid diversions in the future. Since the investigation began, Effingham Health System has worked cooperatively with the DEA and the U.S. Attorney's Office to finalize a plan to address the identified deficiencies in Effingham Health System's handling of controlled substances and entered into an agreement with the DEA to memorialize the plan. Components of the plan include quarterly internal accountability audits and requirements to keep detailed records that track all controlled substances within the hospital."
The Effingham Health System released the following statement on Wednesday: